Research:
Chronic respiratory diseases such as COPD and ARDS account for 5.6% of deaths, ranking at number 4 in the USA’s leading causes of mortality in 2016. During an acute exacerbation of a respiratory disease, a patient’s lungs are unable to provide the necessary gas exchange, O2 delivery and CO2 removal, required for the body’s basic metabolic needs. While clinicians treat the root cause of the exacerbation, extracorporeal respiratory assist devices supplement or replace the lung’s gas exchanging functions. Ms. Omecinski’s research focuses on the development of the The Modular Extracorporeal Lung Assist System (ModELAS). The ModELAS is a compact artificial lung that combines a blood pump and gas exchanging hollow fiber membrane to ease patient physiological stress and demands on care providers during extracorporeal membrane oxygenation (ECMO) or extracorporeal carbon dioxide removal (ECCO2R). The device can provide full oxygenation support for both pediatric and adult patients as well as partial CO2 removal support for adults. The device is currently undergoing 30-day pre-clinical trials in an ovine model.
Presentations:
Honors and Awards:
Ms. Omecinski’s research focuses on the development of the The Modular Extracorporeal Lung Assist System (ModELAS), which is is a compact artificial lung that combines a blood pump and gas exchanging hollow fiber membrane.